STOCK TITAN

If You Invested in Carerx Corporation (CHHHF)

Healthcare · Medical Care Facilities · OTC Link
Looking for the current price? See the CHHHF quote & overview
$1,000 invested 1 Year Ago
$1,166
+16.6% total 17.4% CAGR
Bought on Jul 30, 2025 at $2.06
$1,000 invested 5 Years Ago
N/A
Trading since 2021-12-31

What $1,000 or $10,000 in CHHHF Would Be Worth Today

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Dec 31, 2021
$1,000 $1,166 +17% $556 -44%
$10,000 $11,660 +17% $5,562 -44%

Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for CHHHF

$1,000 Investment Over Time

CHHHF vs S&P 500

Year-by-Year Returns

CHHHF annual performance
Year Start Price End Price Annual Return Cumulative
2021 $4.32 $4.32 +0.0% +0.0%
2022 $3.89 $1.85 -52.4% -57.2%
2023 $2.00 $1.12 -44.0% -74.1%
2024 $1.31 $1.40 +6.9% -67.6%
2025 $1.50 $2.79 +85.4% -35.4%
2026 $2.80 $2.40 -14.2% -44.4%

About Carerx Corporation

Healthcare · OTC Link

CareRx Corp (CHHHF) represents an interest in CareRx Corporation, which is described as Canada's leading provider of pharmacy services to seniors living and other congregate care communities. The company focuses on serving residents in long-term care homes, retirement homes, assisted living facilities and group homes through specialized pharmacy services tailored to complex medication needs.

According to multiple company disclosures, CareRx operates as a national organization with a large network of pharmacy fulfillment centers strategically located across Canada. This network is intended to support timely and cost-effective delivery of medications and to enable quick responses to routine changes in medication management for the residents it serves.

Business focus and service model

CareRx states that it provides pharmacy services to seniors living communities and other congregate care settings. The company reports that it serves tens of thousands of residents across hundreds of communities, including long-term care homes, retirement homes, assisted living facilities and group homes. Its operations are centered on medication management for individuals with complex medication regimens in these care environments.

The company highlights the use of what it describes as best-in-class technology that automates the preparation and verification of multi-dose compliance packaging of medication. This technology is presented as a way to support high levels of safety and adherence for residents who require multiple medications, and to assist staff in care homes with accurate and efficient medication administration.

Operational footprint and technology

CareRx reports that its pharmacy fulfillment centers are strategically located across the country. This structure is intended to allow the company to deliver medications in a timely and cost-effective manner and to respond quickly to routine changes in medication management ordered by prescribers or required by residents’ care plans.

The company also emphasizes automation in its dispensing and packaging processes. By automating preparation and verification of multi-dose compliance packaging, CareRx aims to reduce errors and support consistent medication schedules for residents in the seniors living and congregate care communities it serves.

Role in seniors and congregate care communities

In its public communications, CareRx states that it takes an active role in working with home operator partners. This includes efforts to promote resident health, support staff education and contribute to medication system quality and efficiency in the homes it services. The company positions its pharmacy services as integrated with the broader care environment in long-term care homes, retirement homes, assisted living facilities and group homes.

CareRx has also discussed the opening and consolidation of pharmacy locations to support its operations, such as the opening of a pharmacy in North Burnaby, British Columbia, and the consolidation of existing operations into that location, as part of its efforts to enhance its operational foundation and capacity.

Capital allocation and dividends

The company has announced the initiation of a quarterly dividend on its outstanding common shares and has disclosed subsequent dividend declarations. In its statements, CareRx links the decision to pay a quarterly dividend to its cash generation and capital allocation approach, while also indicating an ongoing focus on investing in organic and inorganic initiatives, capital expenditures for capacity expansion and margin support, and selective acquisition opportunities that management and the board view as attractive.

CareRx has designated its dividends as "eligible dividends" for Canadian income tax purposes and has noted that dividends paid or credited to non-residents of Canada are subject to withholding tax, which may be reduced by treaty. It has also indicated that taxation of dividends paid to U.S. residents is governed by the Internal Revenue Code and advises shareholders to consult a tax advisor regarding tax consequences.

Financial reporting and performance metrics

The company regularly reports financial results for its quarters, including revenue, net income (or loss), and various non-IFRS measures such as EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted EBITDA per share. CareRx explains that these non-IFRS measures are not standardized financial measures recognized under IFRS and cautions that they should not be construed as alternatives to net income or other IFRS measures.

CareRx defines EBITDA as earnings before depreciation and amortization, finance costs, net, and income tax expense (recovery). Adjusted EBITDA is defined as EBITDA before items such as transaction, restructuring and other costs, changes in fair value of contingent consideration liability, impairments, gain or loss on disposal of assets and share-based compensation expense. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by revenue, and Adjusted EBITDA per share is defined as Adjusted EBITDA divided by the weighted average outstanding shares. The company states that it uses these measures to assess performance and that certain lender agreements include Adjusted EBITDA in covenant calculations.

Regulatory and funding environment

CareRx has commented on aspects of the funding environment for long-term care pharmacy services. For example, it has referenced an Executive Officer Notice from the Ontario Ministry of Health announcing a pause in previously scheduled changes to long-term care pharmacy funding that would have reduced the fixed professional fee under a fee-per-bed capitation model. Such disclosures illustrate that the company’s operations are influenced by provincial healthcare funding policies in the long-term care sector.

Engagement with investors

The company frequently announces conference calls and webcasts to discuss its quarterly and annual financial results. These events typically include slide presentations and are made available through the investors section of the company’s website, with archived webcasts accessible for a period of time. Through these communications, CareRx provides updates on its financial performance, operational initiatives and outlook as described in its public disclosures.

CareRx Corporation’s shares trade on the Toronto Stock Exchange under the symbol CRRX, and CHHHF represents an over-the-counter symbol that provides access to the company’s equity for investors outside the primary listing. The company’s disclosures focus on its role as a pharmacy services provider to seniors living and congregate care communities across Canada, supported by a national network of pharmacy fulfillment centers and technology-enabled medication management processes.

Market Cap
$0.2B
Current Price
$2.40
View full CHHHF overview

Frequently Asked Questions

Carerx Corporation investment returns

How much would $1,000 invested in Carerx Corporation be worth today?

If you invested $1,000 in Carerx Corporation (CHHHF) 1 years ago on 2025-07-30, your investment would be worth $1,166 today, representing a +16.6% total return, growing at a compounded rate of 17.4% per year (CAGR).

Has Carerx Corporation outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare CHHHF performance over available time periods.

What is Carerx Corporation's average annual return?

The compound annual growth rate (CAGR) of CHHHF over the past 1 years is 17.4%, growing at a compounded rate each year. Individual years vary significantly — CHHHF's best recent year was 2025 (+85.4%) and worst was 2022 (-52.4%).

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.